Explore 3 Stock Ideas & Industry Insights Download Free Report

News

The Ticker (OTC:NOHO) Outlived the Company Novation Holdings Once Was

NOHO (OTC:NOHO) is a reminder of how tangled the identity of a deep-penny OTC ticker can become. The symbol has long been associated with Novation Holdings Inc, but market-data providers now list the entity under a different corporate name, reflecting the kind of rebranding …

Nitish Kishor | 10 September 2026

NeuroSense Therapeutics (NASDAQ:NRSN) Stock: A Credible ALS Program, a Fragile Share Price

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) occupies a corner of biotech where scientific promise collides with penny-stock economics. The Israel-based clinical-stage company is developing a combination therapy for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease with few effective treatments, yet its Nasdaq-listed shares trade well …

Nitish Kishor | 10 September 2026

InspireMD (NASDAQ: NSPR) Shares Slip: What's Pressuring the Stock and What Comes Next?

A commercial launch, a product recall and a pending FDA decision are colliding at once for InspireMD, Inc (NASDAQ: NSPR), and the stock's latest dip reflects a company in the middle of a delicate transition. The Israel-based, Nasdaq-listed developer of embolic-protection stents is trying …

Nitish Kishor | 10 September 2026

NovaBridge Biosciences (NASDAQ:NBP) Stock: A Rebrand Backed by an FDA Fast Track

A rebrand, a new chief executive and a coveted FDA designation have combined to give NovaBridge Biosciences (NASDAQ:NBP) one of the more eventful years in immuno-oncology's small-cap ranks. The company that most investors knew until recently as I-Mab has reset its identity around a …

Nitish Kishor | 10 September 2026

What's Next for Neuphoria Therapeutics Inc (NASDAQ:NEUP)? Its Stock Waits for the Next Big Signal

● The larger overhang is the proposed Scancell combination and the outcome of the company's strategic review.

Nitish Kishor | 10 September 2026

Niki BioSolutions (NASDAQ:NIKI) Stock: What's Pressuring the Oncology Biopharma

A relatively new ticker on the Nasdaq, Niki BioSolutions, Inc (NASDAQ:NIKI) is drawing attention as a freshly rebranded clinical-stage biopharmaceutical company still establishing its market identity. The shares eased in early-September 2026 trading, a modest single-session slip that fits the pattern of a small, …

Nitish Kishor | 10 September 2026

Neumora Therapeutics (NASDAQ:NMRA) Shares Slip: What's Pressuring NMRA and What Comes Next?

● Neumora Therapeutics develops therapies for central-nervous-system and neuropsychiatric conditions, an area of large unmet need where new mechanisms have historically been difficult to validate.

Nitish Kishor | 10 September 2026

Nemaura Medical's (OTC:NMRD) Glucose-Monitoring Tech Outlived Its Nasdaq Listing

Nemaura Medical, Inc (OTC:NMRD) once traded on the Nasdaq as a promising developer of needle-free glucose monitoring, but today its shares sit in the over-the-counter market at a fraction of a cent, effectively flat in the last closing session. For a name built around …

Nitish Kishor | 10 September 2026

NeuroOne Medical Technologies (NASDAQ: NMTC) Stock Eases Back: Key Levels and Catalysts to Watch

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) has quietly built one of the more tangible commercial stories among micro-cap neurotech names, turning a specialized electrode technology into cleared, revenue-generating products. A slight pullback in the shares is what flagged the ticker, but the durable narrative …

Nitish Kishor | 10 September 2026

A Penny Stock's 100% Jump Was Really Just One Cent Tick for Motus GI Holdings (OTC:MOTS)

Motus GI Holdings (OTC:MOTS) drew notice at the close for a 100% single-session gain, but the arithmetic behind that number is less dramatic than the headline figure suggests. Shares moved from $0.0001 to $0.0002, a rise of exactly one hundredth of a cent, on …

Vinay Lochav | 10 September 2026
Support

Hi! How can we help you today?

Loading…